CALS Patient Activated Learning System (PALS)

Sponsor
Cornell University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04212117
Collaborator
(none)
232
1
2
45.4
5.1

Study Details

Study Description

Brief Summary

The overall goal in this line of inquiry is to test whether the Patient Activated Learning System (PALS) is effective in reducing disparities in access to reliable, easily understood health information, and whether this increased understanding has downstream consequences such as increases in trust in the medical system and self-management behaviors.

Condition or Disease Intervention/Treatment Phase
  • Other: The Patient Activated Learning System (PALS)
  • Other: WebMD
N/A

Detailed Description

Participants will view, in randomized order, PALS or WebMD content on hypertension and on high cholesterol. This study will test knowledge uptake across topics as well as attitudes toward and trust in the information and information providers.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
232 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Can the Digital Patient Activated Learning System Increase Racial Minority Engagement With Health Information? A Multi-Site Pilot Examination in New York State
Actual Study Start Date :
Feb 18, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Arm 1 - Educational Platform, PALS

The Patient Activated Learning System is a free, health education platform written bu trusted MDs.

Other: The Patient Activated Learning System (PALS)
Randomization into PALS arm.

Other: Arm 2 - WebMD

WebMD is a widely used educational platform for health information.

Other: WebMD
Randomization into WebMD arm.

Outcome Measures

Primary Outcome Measures

  1. Knowledge [Day 1, Immediately after reading article]

    as measured by assessment questions on the nutrition information provided

  2. Trust in eHealth [Day 1, Immediately after reading article]

    as measured by e-Health Impact Questionnaire by Kelly et al. on a 5-point likert scale where one is strongly disagree and 5 is strongly agree

  3. E-health usability [Day 1, Immediately after reading article]

    as measured by e-Health Impact Questionnaire scale by Harris et al. on a 5-point likert scale where one is strongly disagree and 5 is strongly agree

  4. Physician trust [Day 1, Immediately after reading article]

    as measured by assessment questions from Wake Forest Physician Trust Scale on a 5-point likert scale where one is strongly disagree and 5 is strongly agree

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patient ≥ 18 years of age.

  • Self-reported hypertension diagnosis.

  • English speaking

  • Passing the cognition screener

  • Able to read in English

  • Patient at designated recruitment clinics

Exclusion Criteria:
  • Non-English speakers

  • Not having self-identified as having hypertension

  • Inability to read in English

  • Being younger than 18

  • Not passing the screener

  • Not being a patient on the participating clinics

Contacts and Locations

Locations

Site City State Country Postal Code
1 Weill Cornell Medicine New York New York United States 10021

Sponsors and Collaborators

  • Cornell University

Investigators

  • Principal Investigator: Neil Lewis, PhD, Cornell University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cornell University
ClinicalTrials.gov Identifier:
NCT04212117
Other Study ID Numbers:
  • 19-08020714
First Posted:
Dec 26, 2019
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 22, 2022